Renée M. Y. Barge

Infectious Complications of Central Venous Catheters Increase the Risk of Catheter-Related Thrombosis in Hematology Patients: A Prospective Study

Cornelis J. van Rooden, Emile F. Schippers, Renée M. Y. Barge et al. · Journal of Clinical Oncology · 2005 · 193 citations · Full text

New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population

Inge Jedema, Nicole M. van der Werff, Renée M. Y. Barge et al. · Blood · 2003 · 172 citations · Full text

Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma

H M Lokhorst, Ingo GH Schmidt-Wolf, Pieter Sonneveld et al. · Haematologica · 2007 · 142 citations · Full text

Internalization and cell cycle-dependent killing of leukemic cells by Gemtuzumab Ozogamicin: rationale for efficacy in CD33-negative malignancies with endocytic capacity

Inge Jedema, Renée M. Y. Barge, Vincent H. J. van der Velden et al. · Leukemia · 2003 · 138 citations

Hematological Malignancy, Gemtuzumab Ozogamicin, Cell Cycle-dependent Killing +12

A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma

Jean‐Louis Kerkhoffs, Jeroen Eikenboom, Martin S. Schipperus et al. · Blood · 2006 · 122 citations · Full text